Moreover, miR-638 and miR-218 can target Breast Cancer 1 Gene (BRCA1) and interfere with tumor cells’ abilities to repair cisplatin-induced DNA damage, increasing the efficiency of platinum salts in BC [114,115]. This evidence concerns the gene BRCA1 and neoplasm.